Release date: 2014-08-27

Recently, a new review article published in the British Journal of Obstetrics and Gynecology (BJOG) clearly pointed out that China must work hard to curb the increasing rate of cesarean section surgery.

The article pointed out that China is one of the countries with the highest cesarean section rate in the world. In 2010, 16 million babies were born, nearly half of which were cesarean section. Although the specific figures are not yet determined, the Chinese cesarean section rate is between 36% and 58% in the Chinese literature. However, in the 1980s, the cesarean section yield was less than 5% and until 1990, the cesarean section rate did not exceed 10%.

This review analyzes the reasons for the increase in cesarean section rate in recent decades. The high cesarean section rate in China may be caused by three aspects: the structure of the obstetric care system, the encouragement of hospital doctors and other staff, and patients. Customary preferences.

Some aspects related to the Chinese obstetric care system and hospital factors have led to an increase in cesarean section rate. These aspects include:

The total number of production is high. Managing a large number of births with limited medical resources may result in higher cesarean delivery rates. Financial incentives also contribute to a higher rate of cesarean delivery than vaginal delivery, with financial incentives including coverage of newborn insurance, income from doctors and hospitals. There are few employees in public hospitals in China and they are controlled by the government. In China, there are an average of 1.5 nurses or midwives per 1,000 people; in the UK there are 9.8 nurses or midwives per 1,000 people. Caesarean section requires less time for care than vaginal delivery. The level of obstetricians and gynaecologists is uneven, with less than 2% of doctors completing master's or doctoral level training. The performance pay of many doctors is based on the number of patients received and the hospitalization costs of patients. Caesarean section is more expensive than vaginal delivery, so these stimuli will allow doctors to guide pregnant women to choose cesarean section.

In addition, pregnant women's preferences are also important factors in the analysis of Chinese cesarean section rates. The authors point out that people under the one-child policy may have too much expectation of childbirth outcomes, and that pregnant women and doctors may consider the advantages of cesarean section to be less than adequate. Fear of uncontrollable pain in the bed, epidural anesthesia, care assistance or family support reinforce this expectation

However, the current method may soon be changed because in November 2013, China’s one-child policy was loosened and the government encouraged couples to have a second child. More repeated cesarean section surgery will change the current risk rate and rate of return.

Susan Hellerstein, assistant professor of obstetrics and gynaecology at the Bryan Women's Hospital in Harvard Medical School and co-author of the study, said: "Since the 1990s, China's cesarean section rate has been less than 10%. Women who have soared to more than 50% have chosen cesarean section to produce. This phenomenon is likely to improve in the future, and we must encourage vaginal delivery by reforming certain aspects of the Chinese obstetric care system, both to reduce the rate of cesarean section. What efforts must be made to take into account safety and effectiveness, and to ensure the health of pregnant women and perinatal women, this is very important in contemporary China."

Mike, associate editor of the British Journal of Gynecology. Mike Marsh said: "This review article reveals the underlying causes of very high cesarean section rates in China. The article clarifies the structure of the health care system, hospitals and maternal preferences are the three leading to high cesarean section rates. Key factors. The factors affecting cesarean section rate pointed out in this article are likely to exist in other countries as well."

In any case, China’s high cesarean section rate is an unquestionable fact, and foreign experts have reasonable reasons for their analysis. As the public, understanding the knowledge about childbirth, choosing the most appropriate mode of delivery is essential for both pregnant women and babies. Childbirth is also risky. See how dangerous it is to have a child.

Source: Shell Network

Anti-Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic, etiology of inflammatory synovitis-based systemic disease. It is characterized by hand, small joints of the joints, symmetry, invasive joint inflammation, often associated with external organ involvement and serum rheumatoid factor positive, can lead to joint deformity and loss of function. According to statistics, the incidence of rheumatoid arthritis in women is 2 to 3 times that of men.It can occur at any age, high incidence of age 40 to 60 years old. People who has rheumatoid arthritis in the late, severe or long-term bedridden patients, due to combined infection, gastrointestinal bleeding, heart, lung or kidney disease can be crisis to life. The main purpose of treatment for Rheumatoid arthritis is to reduce the inflammation of the joints, inhibit the development of lesions and irreversible bone destruction, as far as possible to protect the function of joints and muscles, and ultimately achieve complete disease remission or low disease activity target. Treatment principles include 1. Patient education, 2. General treatment 3. Drug treatment 4. Immune purification 5. Functional exercise 6. Surgical treatment. Anti-Rheumatoid arthritis drug treatment mainly includes non-steroidal anti-inflammatory drugs, slow-acting anti-rheumatic drugs, immunosuppressive agents, immune and biological agents and botanicals. Over the past decade, the treatment of extra-articular lesions and the emergence of new therapies, so that the efficacy of rheumatoid arthritis has been significantly improved. Most patients with rheumatoid arthritis can get a good control or even complete remission.

Anti-Rheumatoid Arthritis,Rheumatoid Arthritis Diagnosis,Arthritis Treatment,Osteoarthritis Treatment,Best Treatment for Rheumatoid Arthritis,Rheumatoid Arthritis Treatment Drugs

Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com